-+ 0.00%
-+ 0.00%
-+ 0.00%

Ishihara Chemical (TSE:4462) Stock Falls As Q2 Earnings Strength Builds

Simply Wall St·11/01/2026 23:26:08
语音播报

Ishihara Chemical just reported Q2 2027 results that showed earnings power still building, even as the stock has lost ground in recent weeks. Coming into the release, the shares had slipped over the past month, yet the business delivered Basic EPS of ¥67.97 on revenue of ¥6,724 million. That combination of solid profit per share and growing top line contrasts with a market that has been marking the price down. The tension today is simple: traders are leaning into recent weakness while the underlying results point to a company still generating healthy chemical sector cash.

Love Ishihara Chemical’s earnings per share but uneasy about the recent share price weakness? Benchmark those results against other quality opportunities using the 14 high quality undervalued stocks

Q2 2027 Earnings Summary

  • Revenue (Q2 2027 vs. Q2 2026): ¥6,724 million vs. ¥6,023 million (up roughly 11.6%)
  • Net Income (Excl. Extra Items, Q2 2027 vs. Q2 2026): ¥927 million vs. ¥811 million (up about 14.4%)
  • Basic EPS (Q2 2027 vs. Q2 2026): ¥67.97 per share vs. ¥59.33 per share (increased approximately 14.6%)
  • Trailing 12 Month Net Profit Margin (TTM, Q2 2027 vs. prior year): 13.9% vs. 10.6% (margin level higher year on year)

Earnings for Ishihara Chemical tell part of the story, but investors who care about what they are paying for the business usually focus on the cash coming in and out of the operation. When you line up Ishihara Chemical's cash flows against the current share price, the stock could be a striking 46% undervalued.

TSE:4462 Trailing 12-Month Revenue & Expenses Breakdown as at Nov 2026
TSE:4462 Trailing 12-Month Revenue & Expenses Breakdown as at Nov 2026

Stronger Ishihara Chemical earnings back a cautious bull story

For a business tied to electronics and industrial supply chains, Ishihara Chemical is putting up the kind of progress bulls like to see. Revenue moved from ¥6,023 million to ¥6,724 million and net income excluding extras climbed from ¥811 million to ¥927 million. Profit per share stepped up to ¥67.97 and the trailing 12 month net margin improved from 10.6% to 13.9%. That combination suggests the core operations are handling input costs and mix reasonably well. This supports a thesis built on resilient specialty chemicals and process know how.

Share pullback keeps bearish worries on the table

Price action tells a different story. The share price closed at ¥2,787 on 30 October 2026, with returns declining about 0.6% over 7 days, 5.5% over 30 days, and 3.1% over 90 days. That weakness, despite firmer earnings, hints at concerns about end market cycles or future order momentum. Bears can also point to the risk that current profitability, including a 13.9% trailing net margin, may reflect favourable conditions that are hard to repeat if electronics or auto related demand softens.

After a 3 month stretch of choppy trading and a sliding share price, it is fair to ask whether Ishihara Chemical’s recent margin strength masks early cracks in demand, pricing power, or product risk. Before assuming this is just routine volatility, review the independent risk analysis for Ishihara Chemical which shows 1 important warning sign

Hunt For Quiet Balance Sheet Strength

Ishihara Chemical shows how firm earnings and a softer share price can pull in different directions. The real opportunity is finding stocks that could be low debt before the market corrects them.

  • Company 1 - 18% below our estimate - expands its salesforce to win more maintenance contracts and deepen service density.
  • Company 2 - 35% below our estimate - rolls out AI tools so employers pay when qualified candidates convert from job ads.
  • Company 3 - 45% below our estimate - shifts security customers onto one platform where subscription bundles replace one off license renewals.

That is three of the list. See the full list of 22 financially solid companies →